Neogenomics Inc Q4 2020 Earnings Call Transcript - Thomson StreetEvents

Neogenomics Inc Q4 2020 Earnings Call Transcript

Neogenomics Inc Q4 2020 Earnings Call Transcript - Thomson StreetEvents
Neogenomics Inc Q4 2020 Earnings Call Transcript
Published Feb 24, 2021
18 pages (11105 words) — Published Feb 24, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of NEO.OQ earnings conference call or presentation 24-Feb-21 1:30pm GMT

  
Brief Excerpt:

...Operator Good morning, ladies and gentlemen, and welcome to the NeoGenomics Quarter 4 and Full Year 2020 Earnings Call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, Doug VanOort, Chairman and CEO of NeoGenomics. Sir, the floor is yours. Douglas M. VanOort ...

  
Report Type:

Transcript

Source:
Company:
Neogenomics Inc
Ticker
NEO.OQ
Time
1:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: David Michael Westenberg - Guggenheim Securities, LLC, Research Division - Analyst : I want to start off with RaDaR, you kind of mentioned. I'm not sure exactly what you can say on that, but the space is getting pretty attractive with some CRC products. So I was just wondering if you can give us some time lines in terms of launch and what you think about in terms of reimbursement. And then if maybe you can talk about product specific, if you could talk about maybe some of the market dynamics. Do you see this quickly transitioning from CRC to other kinds of cancers? And I have a couple of follow-ups.


Question: David Michael Westenberg - Guggenheim Securities, LLC, Research Division - Analyst : Great. I'm going to go back to the commentary you gave in terms of regional dynamics. I think you said ex-Northeast and ex-West Coast, and I think you said 10% dynamics. Could you give a little bit of more indication in terms of what that 10% might represent if it maybe did represent some pent-up demand? I'm just trying to get a feel for, as the economy reopens in the other parts of the regions, if it might look like that, and if there was, in fact, pent-up demand there. And you have a lot of analysts, so I'll hop back in the queue after that. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. FEBRUARY 24, 2021 / 1:30PM, NEO.OQ - Q4 2020 Neogenomics Inc Earnings Call


Question: David Michael Westenberg - Guggenheim Securities, LLC, Research Division - Analyst : And congrats on the retirement.

Table Of Contents

Neogenomics Inc Q3 2021 Earnings Call Transcript – 2021-11-04 – US$ 54.00 – Edited Transcript of NEO.OQ earnings conference call or presentation 4-Nov-21 12:30pm GMT

Neogenomics Inc Q2 2021 Earnings Call Transcript – 2021-08-06 – US$ 54.00 – Edited Transcript of NEO.OQ earnings conference call or presentation 6-Aug-21 12:30pm GMT

Neogenomics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2021-06-09 – US$ 54.00 – Edited Transcript of NEO.OQ presentation 9-Jun-21 7:00pm GMT

Neogenomics Inc Annual Shareholders Meeting Transcript – 2021-05-27 – US$ 54.00 – Edited Transcript of NEO.OQ shareholder or annual meeting 27-May-21 2:00pm GMT

Neogenomics Inc Q1 2021 Earnings and to Discuss Acquisition of Inivata Ltd Call Transcript – 2021-05-05 – US$ 54.00 – Edited Transcript of NEO.OQ earnings conference call or presentation 5-May-21 12:30pm GMT

Neogenomics Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-11 – US$ 54.00 – Edited Transcript of NEO.OQ presentation 11-Jan-21 10:20pm GMT

Neogenomics Inc Q3 2020 Earnings Call Transcript – 2020-10-27 – US$ 54.00 – Edited Transcript of NEO.OQ earnings conference call or presentation 27-Oct-20 12:30pm GMT

Neogenomics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2020-09-14 – US$ 54.00 – Edited Transcript of NEO.OQ presentation 14-Sep-20 1:45pm GMT

Neogenomics Inc Annual Shareholders Meeting Transcript – 2020-05-28 – US$ 54.00 – Edited Transcript of NEO.OQ shareholder or annual meeting 28-May-20 2:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Neogenomics Inc Q4 2020 Earnings Call Transcript" Feb 24, 2021. Alacra Store. May 18, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2020-Neogenomics-Inc-Earnings-Call-T13619410>
  
APA:
Thomson StreetEvents. (2021). Neogenomics Inc Q4 2020 Earnings Call Transcript Feb 24, 2021. New York, NY: Alacra Store. Retrieved May 18, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2020-Neogenomics-Inc-Earnings-Call-T13619410>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.